Business

Cipher Pharmaceuticals Schedules Q3 2021 Earnings Release and Conference Call

Cipher Pharmaceuticals Schedules Q3 2021 Earnings Release and Conference Call C...

articleCipher Pharmaceuticals Inc.November 3, 20213/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-schedules-q3-2021-earnings-release-and-conference-call
Cipher Pharmaceuticals Schedules Q3 2021 Earnings Release and Conference Call

About this update from Cipher Pharmaceuticals Inc.

[{"type":"text","content":"\n \n \n \n Cipher Pharmaceuticals Schedules Q3 2021 Earnings Release and Conference Call\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen3{\nBORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; BORDER-BOTTOM:black 0pt; PADDING-LEFT:0.50em; BORDER-LEFT:black 0pt; PADDING-RIGHT:0.50em\n}\n.prngen2{\nBORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; VERTICAL-ALIGN: TOP; BORDER-BOTTOM:black 0pt; TEXT-ALIGN: LEFT; PADDING-LEFT:0.50em; BORDER-LEFT:black 0pt; PADDING-RIGHT:0.50em\n}\n.prnsbt0{\nBORDER-TOP:0pt\n}\n.prnsbr0{\nBORDER-RIGHT:0pt\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE\n}\n.prnsbl0{\nBORDER-LEFT:0pt\n}\n.prnsbb0{\nBORDER-BOTTOM:0pt\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n \n \n \n OAKVILLE, ON\n \n ,\n \n Nov. 3, 2021\n \n /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (\"\n \n Cipher\n \n \" or \"the\n \n Company\n \n \") today announced that it will release its Q3 2021 financial results on\n \n Thursday, November 11, 2021\n \n . The company will hold a conference call on\n \n Friday, November 12, 2021\n \n at\n \n 8:30am ET\n \n to discuss the results.\n \n \n \n CONFERENCE CALL DETAILS\n \n \n \n \n \n \n \n \n DATE:\n \n \n \n \n \n \n Friday, November 12, 2021\n \n \n \n \n \n \n \n \n TIME:\n \n \n \n \n \n \n 8:30 a.m. EDT\n \n \n \n \n \n \n \n \n DIAL-IN NUMBER:\n \n \n \n \n \n \n (647) 792-1241 or (866) 248-8441\n \n \n \n \n \n \n \n \n CONFERENCE ID:\n \n \n \n \n \n \n 9256970\n \n \n \n \n \n \n \n \n REPLAY DIAL-IN:\n \n \n \n \n \n \n (888) 203-1112 (playback 9256970 #)\n \n Expires November 19, 2021\n \n \n \n \n \n \n \n \n WEBCAST:\n \n \n \n \n \n \n \n https://produceredition.webcasts.com/starthere.jsp?ei=1511252&tp_key=b261dfbc7e\n \n \n \n \n \n \n \n \n \n About Cipher Pharmaceuticals Inc.\n \n \n Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products eit...

More updates from Cipher Pharmaceuticals Inc.